Truist Securities Maintains Buy on Tenet Healthcare, Raises Price Target to $180
Portfolio Pulse from Benzinga Newsdesk
Truist Securities has maintained a Buy rating on Tenet Healthcare and increased its price target from $170 to $180.
October 14, 2024 | 2:27 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Truist Securities has reaffirmed its Buy rating on Tenet Healthcare and increased the price target from $170 to $180, indicating confidence in the company's future performance.
The increase in the price target from $170 to $180 by Truist Securities suggests a positive outlook on Tenet Healthcare's future performance. This is likely to boost investor confidence and could lead to a short-term increase in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100